Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Corrigendum to 'Clinical Response to Tumor Necrosis Factor-α Inhibitor Therapy in the Management of Cardiac Sarcoidosis' [The American Journal of Cardiology 205 (2023) 20-27].
Journal: The American journal of cardiology
Published: April 02, 2026
Clinical Implications of Transmural Late Gadolinium Enhancement in Genotype-Positive Arrhythmogenic and Dilated Cardiomyopathy.
Journal: JACC. Clinical electrophysiology
Published: April 02, 2026
Clinical Characteristics and Prognostic Impact of Multiple Pathogenic Variants Across the Genetic Spectrum of Arrhythmogenic and Dilated Cardiomyopathies.
Journal: Heart rhythm
Published: March 19, 2026
Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy after septal myectomy.
Journal: Heart rhythm
Published: March 05, 2026
Location of LMNA Variants and Clinical Outcomes in Cardiomyopathy.
Journal: JAMA cardiology
Published: March 04, 2026
Incidence of Atrial and Ventricular Arrhythmias in Patients With Titin Truncating Variants Across the Ventricular Morphofunctional Phenotypic Spectrum.
Journal: JACC. Clinical electrophysiology
Published: January 03, 2026
Extravascular implantable cardioverter-defibrillator therapy in patients with genetic heart disease: An early single-center experience.
Journal: Heart rhythm O2
Published: October 31, 2025
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.
Journal: Journal of cardiac failure
Published: October 16, 2025
Domain-Specific Speckle-Tracking Longitudinal Strain in LMNA-Related Cardiomyopathy.
Journal: Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
Published: October 13, 2025
Clinical Characteristics and Cardiac Magnetic Resonance Profile of PKP2 Variant-Positive Patients With a Hypertrophic Cardiomyopathy Phenotype.
Journal: JACC. Advances
Published: October 07, 2025
The artificial intelligence-derived electrocardiographic age gap is associated with adverse clinical outcomes in LMNA-related cardiomyopathy.
Journal: Heart rhythm
Published: October 01, 2025
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.
Journal: medRxiv : the preprint server for health sciences
Published: September 26, 2025
Last Updated: 09/26/2026